Clinical Trials Browser

Neoplasm, Residual × Adjuvants, Pharmaceutic × Clear all

NCT05167604 2021-12-22

Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual